Fourth International Conference--Varicella Zoster Virus

第四届国际会议--水痘带状疱疹病毒

基本信息

  • 批准号:
    6314998
  • 负责人:
  • 金额:
    $ 1.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-03-01 至 2002-04-30
  • 项目状态:
    已结题

项目摘要

Description (provided by applicant): Funds are being requested to support the Fourth International Conference on the Varicella-Zoster Virus (VZV). Previous conferences were held in Bethesda, MD, in 1992 (in conjunction with NIH), in Paris, France in 1994, and in Palm Beach, Florida in 1997. The purpose of these meetings is to provide a forum for researchers, academicians, and clinicians involved in VZV research to have a venue for scientific exchange. The meeting is planned to occur March 3-5, 2001 in LaJolla, CA. VZV is the agent that causes varicella (chickenpox) and zoster (shingles), both of which are important pathogens for humans. Zoster is particularly a medical problem for individuals over the age of 50 years in whom it can only be manifested as a skin rash but also may be associated with severe pain that may persist for months to years after the original illness, a condition termed post herpetic neuralgia (PHN). Topics to be discussed in the 2001 meeting will include clinical topics on the first day because the conference begins on a weekend when clinicians are more likely to be available. One session will be devoted to Varicella and the other to Zoster. The first formal sessions will be devoted to treatment and prevention of varicella and zoster, with an emphasis on new developments in vaccines and antiviral drugs. There will be a special workshop on PCR methods by Perkin-Elmer. On the second day, basic aspects of VZV research will be discussed and will include the topics of virus replication, gene regulation, virus-cell protein interaction, animal models, latency, and host responses. There will also be a series of "State of the Art" lectures by experts in the field who have not presented at past meetings. These talks will include a summary of important data presented at the meeting and will attempt to integrate old and new concepts concerning varicella and zoster.
说明(由申请人提供):正在申请资金,以支持 第四届水痘-带状疱疹病毒(VZV)国际会议。 先前 会议于1992年在马里兰州贝塞斯达举行(与NIH合作), 1994年在法国巴黎,1997年在佛罗里达的棕榈海滩。 的目的 这些会议将为研究人员、学者和 参与VZV研究的临床医生有一个科学交流的场所。 会议计划于2001年3月3日至5日在加利福尼亚州拉霍亚举行。 VZV是引起水痘和带状疱疹的病原体, 两者都是人类的重要病原体。 Zoster尤其是 50岁以上的人的医疗问题, 表现为皮疹,但也可能伴有剧烈疼痛, 可能会持续数月至数年后,原来的疾病,这种情况称为 带状疱疹后神经痛(PHN)。 2001年会议将讨论的主题包括 第一天,因为会议开始在一个周末,当临床医生更多 可能是可用的。 一次会议将专门讨论水痘和 除了Zoster。 第一次正式会议将专门讨论治疗问题, 预防水痘和带状疱疹,重点是 疫苗和抗病毒药物。 将有一个关于PCR方法的特别讲习班 Perkin-Elmer 在第二天,VZV研究的基本方面将是 讨论并将包括病毒复制,基因调控, 病毒-细胞蛋白相互作用、动物模型、潜伏期和宿主反应。 还将有一系列的“最先进的”讲座,由专家在 在过去的会议上没有发言的人。这些会谈将包括 会议上提出的重要数据摘要,并将努力 整合了关于水痘和带状疱疹的新旧概念。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anne A. Gershon其他文献

Live attenuated rubella virus vaccine: comparison of responses to HPV-77-DE5 and RA 27/3 strains
  • DOI:
    10.1097/00000441-198003000-00002
  • 发表时间:
    1980-03-01
  • 期刊:
  • 影响因子:
  • 作者:
    Anne A. Gershon;Henry M. Frey;William Borkowsky;Sharon Steinberg
  • 通讯作者:
    Sharon Steinberg
Live attenuated varicella vaccine: Evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus
  • DOI:
    10.1016/s0022-3476(05)82872-0
  • 发表时间:
    1990-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Maria Tsolia;Anne A. Gershon;Sharon P. Steiberg;Lawrence Gelb; the National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group
  • 通讯作者:
    the National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group
Sa1938 Vaccine-Type Varicella Zoster Virus (VZV) Gastric Ulcerations Leading to Perforation in a 16 Year-Old Previously Healthy, Fully Vaccinated Boy
  • DOI:
    10.1016/s0016-5085(13)61247-0
  • 发表时间:
    2013-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Anne Pierog;Kara G. Margolis;Anne A. Gershon
  • 通讯作者:
    Anne A. Gershon
Tu2011 Enteric Zoster: Human Occurrence and Development of a Guinea Pig Model
  • DOI:
    10.1016/s0016-5085(13)63367-3
  • 发表时间:
    2013-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jason J. Chen;Anne A. Gershon;Alexander Diacou;Michael D. Gershon
  • 通讯作者:
    Michael D. Gershon

Anne A. Gershon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anne A. Gershon', 18)}}的其他基金

TRAINING IN PEDIATRIC INFECTIOUS DISEASE
儿科传染病培训
  • 批准号:
    6169081
  • 财政年份:
    1998
  • 资助金额:
    $ 1.6万
  • 项目类别:
Training in Pediatric Infectious Disease
儿科传染病培训
  • 批准号:
    7101062
  • 财政年份:
    1998
  • 资助金额:
    $ 1.6万
  • 项目类别:
Training in Pediatric Infectious Disease
儿科传染病培训
  • 批准号:
    7487462
  • 财政年份:
    1998
  • 资助金额:
    $ 1.6万
  • 项目类别:
TRAINING IN PEDIATRIC INFECTIOUS DISEASE
儿科传染病培训
  • 批准号:
    6372843
  • 财政年份:
    1998
  • 资助金额:
    $ 1.6万
  • 项目类别:
Training in Pediatric Infectious Disease
儿科传染病培训
  • 批准号:
    7278718
  • 财政年份:
    1998
  • 资助金额:
    $ 1.6万
  • 项目类别:
TRAINING IN PEDIATRIC INFECTIOUS DISEASE
儿科传染病培训
  • 批准号:
    2886252
  • 财政年份:
    1998
  • 资助金额:
    $ 1.6万
  • 项目类别:
TRAINING IN PEDIATRIC INFECTIOUS DISEASE
儿科传染病培训
  • 批准号:
    2651759
  • 财政年份:
    1998
  • 资助金额:
    $ 1.6万
  • 项目类别:
Training in Pediatric Infectious Disease
儿科传染病培训
  • 批准号:
    6944950
  • 财政年份:
    1998
  • 资助金额:
    $ 1.6万
  • 项目类别:
TRAINING IN PEDIATRIC INFECTIOUS DISEASE
儿科传染病培训
  • 批准号:
    6510142
  • 财政年份:
    1998
  • 资助金额:
    $ 1.6万
  • 项目类别:
Training in Pediatric Infectious Disease
儿科传染病培训
  • 批准号:
    6800871
  • 财政年份:
    1998
  • 资助金额:
    $ 1.6万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 1.6万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 1.6万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 1.6万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 1.6万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 1.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了